Results 131 to 140 of about 30,153 (204)

Aromatase Inhibitor-Induced Carpal Tunnel Syndrome Immunohistochemical Analysis and Clinical Evaluation: An Observational, Cross-Sectional, Case-Control Study. [PDF]

J Clin Med
Molayem I, Marcovici LL, Gradini R, Mancini M, Taccogna S, Pagnotta A.   +5 more
europepmc   +1 more source

The Risk of Cardiovascular Disease following Aromatase Inhibitor Therapy for Breast Cancer in Postmenopausal Women: A Systematic Review and Meta-Analysis. [PDF]

Breast Care (Basel)
Berbari E, Anees A, Kaur R, Ayeni FE, Edirimanne S.   +4 more
europepmc   +1 more source

Adult Height Following Prepubertal Treatment With Antiandrogen, Aromatase Inhibitor, and Reduced Hydrocortisone in CAH.

J Clin Endocrinol Metab
Merke DP, Mallappa A, Parker M, Sukin C, Kulkarni SE, Keil MF, Van Ryzin C, Hill SC, Reynolds JC, Cutler GB, Sinaii N.   +10 more
europepmc   +1 more source

Red Wine as an Aromatase Inhibitor: A Narrative Review. [PDF]

Cureus
Pergolizzi J, LeQuang JAK, Wagner M, Salah R, Magnusson P, Varrassi G.   +5 more
europepmc   +1 more source

Effects of the efficacy of the <i>Yi Shen Tiao Gan</i> formula on aromatase inhibitor associated musculoskeletal syndrome: a randomized controlled trial. [PDF]

Front Pharmacol
Zhang Y, Chu M, Ye M, Cheng Y, Cong H, Yin Y, Chen H.   +6 more
europepmc   +1 more source

Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors. [PDF]

JNCI Cancer Spectr
Huang Y, Kwan ML, Heckbert SR, Smith NL, Othus M, Laurent CA, Roh JM, Rillamas-Sun E, Lee VS, Kolevska T, Cheng RK, Irribarren C, Nguyen-Huynh M, Hershman DL, Kushi LH, Greenlee H.   +15 more
europepmc   +1 more source

Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival. [PDF]

ESMO Open
Crown J, Stroyakovskii D, Yardley DA, Huang CS, Fasching PA, Bardia A, Chia S, Im SA, Martin M, Xu B, Barrios CH, Untch M, Moroose R, Hurvitz SA, Hortobagyi GN, Slamon DJ, Visco F, Spera G, Zarate JP, Halligan D, Li Z, Loi S.   +21 more
europepmc   +1 more source

Dalpiciclib plus aromatase inhibitor versus neoadjuvant chemotherapy for ER-positive, HER2-negative breast cancer. [PDF]

Front Oncol
Wang H, Zhang G, Gao W, Li S, Yang S, Zhang X, Wang J, Li C, Gao S, Geng C.   +9 more
europepmc   +1 more source

Yi Shen Tiao Gan decoction alleviates aromatase inhibitor-related bone loss by promoting H-type vessel formation. [PDF]

Transl Oncol
Chu M, Zhang Y, Ye M, Yin Y, Chen H.
europepmc   +1 more source

A detailed transcriptome study uncovers the epigenetic characteristics associated with Aromatase inhibitor-induced masculinization in Takifugu rubripes larvae gonads. [PDF]

BMC Genomics
Shen X, Yan H, Hu M, Zhou H, Zhang Q, Gao R, Liu Q, Sun Q.   +7 more
europepmc   +1 more source